![header Medical worker speaking](https://psrota-r.org/wp-content/uploads/elementor/thumbs/header-e1687970568651-q8mx8ebukbt3jrqk9iqt55hpebhk6wlh70zeh4et9c.jpg)
On June 6, 2023, The U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), published National Model Standards for Peer Support Certification (see attached) for substance use, mental health and family peer workers.
![FDA FDA](https://psrota-r.org/wp-content/uploads/elementor/thumbs/FDA-q7oky2dnalztn3o1zewcc64ts9j6r5jkt4x9z2e5y8.jpg)
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD).
![ROTA-R-Template white house](https://psrota-r.org/wp-content/uploads/elementor/thumbs/ROTA-R-Template-q7c2zfbv9h9zyz3hnynd4c9q4skhf72c1b7oa6a1eo.jpg)
Xylazine’s growing role in overdose deaths nationwide prompts Administration to make this designation for the first time in U.S. history
![niaaa-product_psrota-r-news III niaaa-product_psrota-r-news III](https://psrota-r.org/wp-content/uploads/elementor/thumbs/niaaa-product_psrota-r-news-III-q78mu8z2idb8c8tpimwocme2oqkkfdqrwxw0surrts.png)
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) created brief videos series on a variety of alcohol related topics called Short Takes.
![ROTA-R-Template guam](https://psrota-r.org/wp-content/uploads/elementor/thumbs/ROTA-R-Template-1-q6lxz8vsc5cbtg4xrapt5dk409xz35zctsj9eots4g.jpg)
The Guam Behavioral Health and Wellness Center and Pacific Southwest Addiction Technology Transfer Center cordially invite you to save the date for Guam’s Fourth Annual Conference on Substance Use Disorders among Pacific Islanders.